Axsome Therapeutics to Present Five Abstracts Including New
NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
Stay updated with breaking news from Repeatable Battery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
Aerobic exercise is a nonpharmacological intervention that has been shown to improve not only cardiovascular fitness, but also depressive symptoms, and cognition following traumatic brain injury.
Hormone replacement therapy may be an effective strategy for reducing the risk for Alzheimer disease in women who are carriers of the APOE4 gene.
Examining the clinical features and cognitive outcomes of young adults with treatment-resistant depression undergoing electroconvulsive therapy. Read more
Women are at greater risk for dementia than men, probably because of waning estrogen levels following menopause. Estrogen is a key female hormone linked to reproductive, sexual, and neurological functions. A new study published in the journal Alzheimer's Research & Therapy examines how hormone replacement works in women with a high genetic risk for AD.